Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration for Fluocinolone Acetonide Topical Oil, 0.01 percent (Body Oil),...
Dr Reddy’s Laboratories Ltd. announced its consolidated financial results for the quarter and half year ended September 30, 2018 under International Financial Reporting Standards (IFRS). The...
Alembic Pharmaceuticals announced that the United States Food and Drug Administration (US FDA) has completed an inspection of its general oral solid formulation facility at Panelav,...
Eppendorf India and Sree Sastha Institute of Engineering and Technology have signed a memorandum of understanding (MoU) for training students of Biotechnology on various modules. Eppendorf...
Indian software services exporter Wipro Ltd called out its healthcare services business in the United States as a challenge as uncertainties over Obamacare meant insurers are...
LifeCell International, India’s premier stem cell bank and mother & baby diagnostics company today announced the launch of RightStart – the world’s first Integrated DNA testing...
Piramal Enterprises reported a 25 percent year-on-year growth in consolidated net profit at ₹480 crore for the three months to September, driven by a healthy loan...
Alkem Laboratories Ltd. will organize a conference call for investors and analysts on Friday, November 2, 2018 at 5:00 pm 1ST to discuss its Q2FY19 and...
Cadila Healthcare has signed (jointly with Zydus Wellness) the Definitive Agreements to acquire the subsidiary of Kraft Heinz, Heinz India. This will include the brands Complan,...
Royal Philips, a global leader in health technology, today announced the launch of its first global start-up collaboration program involving Philips’ innovation hubs in Cambridge (US),...
Alembic Pharmaceuticals Limited reported its consolidated financial results for the half year ending 30th September 2018. Financial highlights: Net sales for the quarter up 43 percent...
Sun Pharmaceutical Industries Ltd. announced that moderate-to-severe psoriasis treatment ILUMYATM (tildrakizumab-asmn) 100 mg/mL is now available in the United States. ILUMYATM is an injectable interleukin-23 (IL-23)...
Drug firm Zydus Cadila said it has received final nod from the US health regulator to market generic Clobazam tablets used for treatment of seizures caused...
Drug major Cipla said its South African subsidiary has completed the acquisition of pharma firm Mirren (Pty) Ltd. Cipla Medpro South Africa (Pty) Ltd has completed...
Pharmaceutical company Mylan N.V. announced that it has initiated the commercial launch of Hulio, a biosimilar to AbbVie’s Humira (adalimumab), across major markets in Europe. The...
Copyright © 2024 Medical Buyer